Home
About
Mission
Leadership
Research
Discovery Teams
Areas of Focus
Outreach
Drug Discovery Online
Community Outreach
Warren Center Lecture Series
News
Careers
Funding
Contact
Invest
Feb
25
Feb 25
Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases.
Guest User
by: Soleno Therapeutics
Apr 13
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Feb 11
Discovery shows how to treat heart attacks; drug development underway